Drug Shortage Report for PMS-TERAZOSIN
Report ID | 32160 |
Drug Identification Number | 02243520 |
Brand name | PMS-TERAZOSIN |
Common or Proper name | TERAZOSIN |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | TERAZOSIN |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | G04CA |
ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-12-08 |
Estimated end date | 2018-04-30 |
Actual end date | 2018-04-17 |
Shortage status | Resolved |
Updated date | 2018-04-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2018-04-19 | French | Compare |
v6 | 2018-04-19 | English | Compare |
v5 | 2018-03-19 | French | Compare |
v4 | 2018-03-19 | English | Compare |
v3 | 2017-12-09 | English | Compare |
v2 | 2017-12-08 | French | Compare |
v1 | 2017-12-08 | English | Compare |
Showing 1 to 7 of 7